NCT07319377 is a NA clinical trial of exoDTx in Sarcopenia, sponsored by Exosystems.

Who is sponsoring NCT07319377?

NCT07319377 is sponsored by Exosystems.

What drugs are being tested in NCT07319377?

Interventions in NCT07319377: exoDTx, Self-exercise (Educational Material).

What condition does NCT07319377 study?

NCT07319377 studies Sarcopenia.

Is NCT07319377 still recruiting?

NCT07319377 is currently recruiting now. Last updated 6 January 2026.

Last reviewed 2026-01-06 · How we verify

NCT07319377

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)

Recruiting now NA Last updated 6 January 2026

What this trial tests

NA trial testing exoDTx in Sarcopenia in 130 participants. Currently enrolling.

Timeline

28 November 2025

Primary endpoint
20 June 2026

25 September 2026

Quick facts

Lead sponsor	Exosystems
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	130
Start date	28 November 2025
Primary completion	20 June 2026
Estimated completion	25 September 2026
Sites	3 locations across South Korea

Drugs / interventions tested

exoDTx
Self-exercise (Educational Material)

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Exosystems

Who can join

Adults 50 to 85, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to demonstrate that the use of a digital therapeutic device (exoDTx) in patients with sarcopenia is superior to self-exercise in terms of muscle strength improvement and safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07319377 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Exosystems
Last refreshed: 6 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07319377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing